1h Free Analyst Time
The publisher has been monitoring the porcine vaccine market and it is poised to grow by $794.67 mn during 2022-2026 progressing at a CAGR of 7.01% during the forecast period. The report on the porcine vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of porcine diseases, increase in R and D expenditure for the development of porcine vaccines, and growing animal healthcare expenditure.
The porcine vaccine market analysis includes the product segment and geographic landscape.
The porcine vaccine market is segmented as below:
By Product
- Intravenous
- Intramuscular
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the strategic initiatives by market vendors as one of the prime reasons driving the porcine vaccine market growth during the next few years. Also, growing demand for pork and gelatin and increasing government initiatives for funding the animal husbandry sector will lead to sizable demand in the market.
The report on porcine vaccine market covers the following areas:
- Porcine vaccine market sizing
- Porcine vaccine market forecast
- Porcine vaccine market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading porcine vaccine market vendors that include Bimeda Inc., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., FATRO SpA, Formosa Biomedical Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Phibro Animal Health Corp., Veterinary Provisions Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc. Also, the porcine vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Intravenous - Market size and forecast 2021-2026
Exhibit 28: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
5.4 Intramuscular - Market size and forecast 2021-2026
Exhibit 32: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Product
Exhibit 40: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Bioveta AS
Exhibit 89: Bioveta AS - Overview
Exhibit 90: Bioveta AS - Product / Service
Exhibit 91: Bioveta AS - Key offerings
10.4 Boehringer Ingelheim International GmbH
Exhibit 92: Boehringer Ingelheim International GmbH - Overview
Exhibit 93: Boehringer Ingelheim International GmbH - Business segments
Exhibit 94: Boehringer Ingelheim International GmbH - Key news
Exhibit 95: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 96: Boehringer Ingelheim International GmbH - Segment focus
10.5 Ceva Sante Animale
Exhibit 97: Ceva Sante Animale - Overview
Exhibit 98: Ceva Sante Animale - Product / Service
Exhibit 99: Ceva Sante Animale - Key offerings
10.6 FATRO SpA
Exhibit 100: FATRO SpA - Overview
Exhibit 101: FATRO SpA - Product / Service
Exhibit 102: FATRO SpA - Key offerings
10.7 Formosa Biomedical Inc.
Exhibit 103: Formosa Biomedical Inc. - Overview
Exhibit 104: Formosa Biomedical Inc. - Product / Service
Exhibit 105: Formosa Biomedical Inc. - Key offerings
10.8 LABORATORIOS HIPRA SA
Exhibit 106: LABORATORIOS HIPRA SA - Overview
Exhibit 107: LABORATORIOS HIPRA SA - Product / Service
Exhibit 108: LABORATORIOS HIPRA SA - Key offerings
10.9 Merck and Co. Inc.
Exhibit 109: Merck and Co. Inc. - Overview
Exhibit 110: Merck and Co. Inc. - Business segments
Exhibit 111: Merck and Co. Inc. - Key news
Exhibit 112: Merck and Co. Inc. - Key offerings
Exhibit 113: Merck and Co. Inc. - Segment focus
10.10 Phibro Animal Health Corp.
Exhibit 114: Phibro Animal Health Corp. - Overview
Exhibit 115: Phibro Animal Health Corp. - Business segments
Exhibit 116: Phibro Animal Health Corp. - Key offerings
Exhibit 117: Phibro Animal Health Corp. - Segment focus
10.11 Virbac Group
Exhibit 118: Virbac Group - Overview
Exhibit 119: Virbac Group - Business segments
Exhibit 120: Virbac Group - Key news
Exhibit 121: Virbac Group - Key offerings
Exhibit 122: Virbac Group - Segment focus
10.12 Zoetis Inc.
Exhibit 123: Zoetis Inc. - Overview
Exhibit 124: Zoetis Inc. - Business segments
Exhibit 125: Zoetis Inc. - Key news
Exhibit 126: Zoetis Inc. - Key offerings
Exhibit 127: Zoetis Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Product - Market share 2021-2026 (%)
Exhibits 25: Data Table on Product - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Product
Exhibits 27: Data Table on Comparison by Product
Exhibits 28: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Product ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Bioveta AS - Overview
Exhibits 90: Bioveta AS - Product / Service
Exhibits 91: Bioveta AS - Key offerings
Exhibits 92: Boehringer Ingelheim International GmbH - Overview
Exhibits 93: Boehringer Ingelheim International GmbH - Business segments
Exhibits 94: Boehringer Ingelheim International GmbH - Key news
Exhibits 95: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 96: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 97: Ceva Sante Animale - Overview
Exhibits 98: Ceva Sante Animale - Product / Service
Exhibits 99: Ceva Sante Animale - Key offerings
Exhibits 100: FATRO SpA - Overview
Exhibits 101: FATRO SpA - Product / Service
Exhibits 102: FATRO SpA - Key offerings
Exhibits 103: Formosa Biomedical Inc. - Overview
Exhibits 104: Formosa Biomedical Inc. - Product / Service
Exhibits 105: Formosa Biomedical Inc. - Key offerings
Exhibits 106: LABORATORIOS HIPRA SA - Overview
Exhibits 107: LABORATORIOS HIPRA SA - Product / Service
Exhibits 108: LABORATORIOS HIPRA SA - Key offerings
Exhibits 109: Merck and Co. Inc. - Overview
Exhibits 110: Merck and Co. Inc. - Business segments
Exhibits 111: Merck and Co. Inc. - Key news
Exhibits 112: Merck and Co. Inc. - Key offerings
Exhibits 113: Merck and Co. Inc. - Segment focus
Exhibits 114: Phibro Animal Health Corp. - Overview
Exhibits 115: Phibro Animal Health Corp. - Business segments
Exhibits 116: Phibro Animal Health Corp. - Key offerings
Exhibits 117: Phibro Animal Health Corp. - Segment focus
Exhibits 118: Virbac Group - Overview
Exhibits 119: Virbac Group - Business segments
Exhibits 120: Virbac Group - Key news
Exhibits 121: Virbac Group - Key offerings
Exhibits 122: Virbac Group - Segment focus
Exhibits 123: Zoetis Inc. - Overview
Exhibits 124: Zoetis Inc. - Business segments
Exhibits 125: Zoetis Inc. - Key news
Exhibits 126: Zoetis Inc. - Key offerings
Exhibits 127: Zoetis Inc. - Segment focus
Exhibits 128: Inclusions checklist
Exhibits 129: Exclusions checklist
Exhibits 130: Currency conversion rates for US$
Exhibits 131: Research methodology
Exhibits 132: Validation techniques employed for market sizing
Exhibits 133: Information sources
Exhibits 134: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global porcine vaccine market: Bimeda Inc., Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., FATRO SpA, Formosa Biomedical Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Phibro Animal Health Corp., Veterinary Provisions Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is strategic initiatives by market vendors.'
According to the report, one of the major drivers for this market is the increasing prevalence of porcine diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bimeda Inc.
- Bioveta AS
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Elanco Animal Health Inc.
- FATRO SpA
- Formosa Biomedical Inc.
- LABORATORIOS HIPRA SA
- Merck and Co. Inc.
- Phibro Animal Health Corp.
- Veterinary Provisions Inc.
- Vetoquinol SA
- Virbac Group
- Zoetis Inc.
